Octagon Capital Advisors as of Sept. 30, 2024
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 41 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 13.5 | $87M | 3.0M | 28.84 | |
| Verona Pharma Sponsored Ads (VRNA) | 8.2 | $53M | 1.8M | 28.77 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 8.2 | $53M | 1.2M | 43.89 | |
| Insmed Com Par $.01 Call Option (INSM) | 7.8 | $50M | 687k | 73.00 | |
| Dianthus Therapeutics (DNTH) | 7.4 | $48M | 1.7M | 27.38 | |
| Arrivent Biopharma (AVBP) | 7.2 | $46M | 2.0M | 23.50 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 5.0 | $32M | 2.0M | 15.99 | |
| Nuvation Bio Com Cl A (NUVB) | 4.3 | $28M | 12M | 2.29 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 3.6 | $23M | 1.1M | 20.63 | |
| Ocular Therapeutix (OCUL) | 3.3 | $21M | 2.4M | 8.70 | |
| Miragen Therapeutics (VRDN) | 3.1 | $20M | 870k | 22.75 | |
| Perspective Therapeutics Com New (CATX) | 3.0 | $19M | 1.4M | 13.35 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.7 | $17M | 3.0M | 5.69 | |
| Cogent Biosciences (COGT) | 2.2 | $14M | 1.3M | 10.80 | |
| Bridgebio Pharma (BBIO) | 2.2 | $14M | 552k | 25.46 | |
| Pharvaris N V (PHVS) | 1.8 | $12M | 621k | 18.52 | |
| Dyne Therapeutics (DYN) | 1.5 | $9.4M | 263k | 35.92 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.4 | $9.2M | 4.6M | 2.01 | |
| Gossamer Bio (GOSS) | 1.4 | $9.1M | 9.2M | 0.99 | |
| Allovir (ALVR) | 1.4 | $9.1M | 11M | 0.81 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.4 | $8.7M | 1.1M | 7.99 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.2 | $7.5M | 130k | 57.54 | |
| Mineralys Therapeutics (MLYS) | 1.1 | $7.3M | 600k | 12.11 | |
| Regulus Therapeutics (RGLS) | 1.0 | $6.7M | 4.3M | 1.57 | |
| Ventyx Biosciences (VTYX) | 0.8 | $5.2M | 2.4M | 2.18 | |
| Tenaya Therapeutics (TNYA) | 0.8 | $5.0M | 2.6M | 1.93 | |
| Cybin | 0.7 | $4.4M | 490k | 8.89 | |
| Reneo Pharmaceuticals (RPHM) | 0.6 | $3.8M | 2.3M | 1.70 | |
| Unicycive Therapeutics (UNCY) | 0.5 | $3.5M | 8.6M | 0.41 | |
| Pepgen (PEPG) | 0.5 | $3.2M | 376k | 8.55 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.4 | $2.6M | 250k | 10.45 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $2.6M | 594k | 4.35 | |
| Annexon (ANNX) | 0.4 | $2.4M | 400k | 5.92 | |
| Mersana Therapeutics (MRSN) | 0.3 | $1.9M | 992k | 1.89 | |
| Century Therapeutics (IPSC) | 0.2 | $1.1M | 667k | 1.71 | |
| Aerovate Therapeutics (AVTE) | 0.2 | $973k | 465k | 2.09 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $715k | 312k | 2.29 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $639k | 176k | 3.63 | |
| Neurogene (NGNE) | 0.1 | $629k | 15k | 41.96 | |
| Rapt Therapeutics (RAPT) | 0.1 | $587k | 292k | 2.01 | |
| Nkarta (NKTX) | 0.1 | $542k | 120k | 4.52 |
